CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $552.78 | $66K | 28,756 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −437 | $553.97 | $242K | 28,319 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,158 | $555.21 | $643K | 27,161 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,205 | $556.06 | $670K | 25,956 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,840 | $557.19 | $1.0M | 24,116 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,679 | $558.31 | $937K | 22,437 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −860 | $559.47 | $481K | 21,577 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −616 | $560.18 | $345K | 20,961 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −645 | $561.56 | $362K | 20,316 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −619 | $562.75 | $348K | 19,697 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −539 | $563.47 | $304K | 19,158 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −82 | $564.43 | $46K | 19,076 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −200 | $566.01 | $113K | 18,876 |
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 112,500 | ||
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $552.65 | $44K | 49,933 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $553.96 | $222K | 49,533 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,209 | $555.25 | $671K | 48,324 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,219 | $556.19 | $678K | 47,105 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,386 | $557.21 | $772K | 45,719 |
Page 129 of 171 · 3,408 trades